|
|
ARDS: Searching for Effective TherapiesPublished by: Datamonitor Published: Jul. 5, 2002 - 19 Pages Table of ContentsEXECUTIVE SUMMARY INTRODUCTION TO ARDS Disease Definition Causes of ARDS Epidemiology TREATMENT APPROACHES Mechanical ventilation Unmet needs in ARDS therapy OUTLOOK FOR DRUG THERAPY Surfactants Product pipeline Analysis of potential new therapies Market considerations Intellectual Property Disputes Safety Concerns REASON FOR CAUTIOUS OPTIMISM © Datamonitor 2002. All Rights Reserved. AbstractIntroduction: Surfactants, long the primary treatment for infant respiratory distress syndrome (IRDS), are now being investigated for application to Acute Respiratory Distress Syndrome (ARDS). To date, however, clinical trials have produced mixed results. Scope of this Report: * Analysis based on review of the most recent published reports of clinical trials results evaluating potential ARDS therapies * Summary of treatment practices and unmet clinical need in ARDS. Report Highlights: Five surfactants are already marketed for the related condition, IRDS. Surfactants remain the most promising class of drugs in development for ARDS. While other drug classes, such as glucocorticoids, have also been investigated for use in ARDS therapy, trial results have proved disappointing. Key Reasons to Buy this Report: * To evaluate potential commercial opportunities in a market having no approved drugs * To assess competitors in the respiratory marketGet Full Details About This Report >> |
|
|||
|
About MarketResearch.com
|
||||